Stocks closed solidly higher on Thursday for the fourth straight session as investor optimism about the Trump administration continues to run high.

Elevance Health Inc.'s stock rose 2% Thursday and boosted other health-insurance stocks after the company delivered better-than-expected earnings and forecast growth for 2025, easing investor concerns ...

U.S. stocks are drifting near a record as Wall Street’s recent rally loses some momentum. The S&P 500 slipped 0.1% in early trading Thursday, a day after after pulling to the edge of its all-time high ...

Shares of Elevance Health jumped early Thursday in response to better-than-expected fourth- quarter results, and a generally optimistic outlook for the coming year. A week after UnitedHealth Group ...

Elevance Health on Thursday posted a better-than-feared fourth-quarter profit, which came as a relief to investors who await a turnaround in the Medicaid business which has been battling with high ...

For the quarter ended December 2024, Elevance Health (ELV) reported revenue of $44.99 billion, up 6% over the same period last year. EPS came in at $3.84, compared to $5.62 in the year-ago quarter.

Elevance Health (ELV) came out with quarterly earnings of $3.84 per share, beating the Zacks Consensus Estimate of $3.80 per share. This compares to earnings of $5.62 per share a year ago. These ...

Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for ...